Table 1.
Group | Age | Sex (male/female) | BMI (kg/m2) | Duration of disease (yr) |
FD group (n = 70) | 44.82 ± 13.41 | 27/43 | 21.38 ± 3.87 | 2.01 ± 1.32 |
Control group (n = 72) | 40.70 ± 6.39 | 22/48 | 21.20 ± 2.95 | 1.89 ± 1.73 |
t-test value | t = 2.347 | χ2 = 0.785 | t = 0.312 | t = 0.464 |
P value | 0.020 | 0.376 | 0.755 | 0.644 |
H. pylori therapeutic group | 42.73 ± 11.97 | 10/18 | 20.98 ± 3.27 | 2.10 ± 1.12 |
Conventional therapeutic group | 43.79 ± 14.28 | 9/12 | 22.08 ± 2.96 | 1.97 ± 1.28 |
H. pylori-negative group | 45.82 ± 12.83 | 8/13 | 21.16 ± 3.64 | 1.95 ± 1.31 |
t-test value | F = 2.191 | F = 2.315 | F = 1.923 | F = 1.872 |
P value | 0.266 | 0.221 | 0.397 | 0.426 |
BMI: Body mass index; FD: Functional dyspepsia; H. pylori: Helicobacter pylori.